Ilika, results broadly in-line, is commercialising solid-state lithium ion battery technology and establishing itself as a UK sector flagship. The Goliath next-gen platform for EVs aligns closely with UK industrial strategy, leveraging UK grant funding & access to the UK Battery Industrialisation Centre (UKBIC) to accelerate market entry; ‘A sample’ prototypes expected to be in tier-1 automotive partner hands, by the end of the year. Ilika’s unique Stereax micro SSB platform for high-value medical device markets targets early commercial revenues this year, via high-quality US manufacturing partner and licensee, Cirtec medical. Ilika’s rising star is evinced post-period by both this week’s latest £1.2m APC UK govt grant award for further Goliath progression and strong investor support in May via an oversubscribed c.£4m retail & institutional placing.
